| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 12.388 | 9.735 | 15.629 | 22.444 |
| Total Income - EUR | - | - | - | - | - | - | 12.388 | 9.735 | 15.629 | 22.444 |
| Total Expenses - EUR | - | - | - | - | - | - | 91 | 2.227 | 1.511 | 2.358 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 12.297 | 7.508 | 14.118 | 20.086 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 11.182 | 7.216 | 11.859 | 16.872 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Standardiab Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 11.520 | 1.725 | 14.281 | 11.479 |
| Inventories | - | - | - | - | - | - | 106 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 49 | 0 | 1.766 | 4.753 |
| Cash | - | - | - | - | - | - | 11.366 | 1.725 | 12.515 | 6.726 |
| Shareholders Funds | - | - | - | - | - | - | 11.223 | 1.547 | 13.402 | 9.745 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 298 | 178 | 879 | 1.734 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Standardiab Med S.r.l.